Classification
- Anatomical main groupCCardiovascular system
- Therapeutic subgroupC02
- Pharmacological subgroupC02A
- Chemical subgroupC02AC
- Chemical substanceC02AC02Guanfacine
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 24 registrations
- AG-Guanfacine XR1 MG · Tablet (Extended-Release) · Angita Pharma INC.
- AG-Guanfacine XR4 MG · Tablet (Extended-Release) · Angita Pharma INC.
- AG-Guanfacine XR2 MG · Tablet (Extended-Release) · Angita Pharma INC.
- AG-Guanfacine XR3 MG · Tablet (Extended-Release) · Angita Pharma INC.
Spain
AEMPS · 11 registrations
- Intuniv 1mg comprimidos de liberacion prolongada1,14 mg · comprimido de liberación prolongada · Takeda Pharmaceuticals International Ag Ireland Branch
- Intuniv 2mg comprimidos de liberacion prolongada2,28 mg · comprimido de liberación prolongada · Takeda Pharmaceuticals International Ag Ireland Branch
At a glance
- ATC code
- C02AC02
- ATC group
- Cardiovascular system
- Registers
- 6
- Historical lists
- 1
- Registrations
- 55
- With their own page
- 54
- Companies
- 15
All medicines with Guanfacine
Human medicines from every register that match Guanfacine by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
55 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Guanfacine Hydrochloride | United States | 1MG BASE, 2MG BASE | tablet | Marketed | Ajanta Pharma LTD |
| Guanfacine Hydrochloride | United States | 1MG BASE, 2MG BASE, 3MG BASE … | tablet, extended release | Marketed | Twi Pharms |
| AG-Guanfacine XR | Canada | 1 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| AG-Guanfacine XR | Canada | 3 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| AG-Guanfacine XR | Canada | 2 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| AG-Guanfacine XR | Canada | 4 MG | Tablet (Extended-Release) | Marketed | Angita Pharma INC. |
| Apo-Guanfacine XR | Canada | 4 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Apo-Guanfacine XR | Canada | 1 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Apo-Guanfacine XR | Canada | 3 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Apo-Guanfacine XR | Canada | 2 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Pro-Guanfacine XR | Canada | 3 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Pro-Guanfacine XR | Canada | 1 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Pro-Guanfacine XR | Canada | 4 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Pro-Guanfacine XR | Canada | 2 MG | Tablet (Extended-Release) | Marketed | Pro Doc Limitee |
| Jamp Guanfacine XR | Canada | 1 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Jamp Guanfacine XR | Canada | 3 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Jamp Guanfacine XR | Canada | 4 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Jamp Guanfacine XR | Canada | 2 MG | Tablet (Extended-Release) | Marketed | Jamp Pharma Corporation |
| Sandoz Guanfacine XR | Canada | 4 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Sandoz Guanfacine XR | Canada | 1 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Sandoz Guanfacine XR | Canada | 3 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Sandoz Guanfacine XR | Canada | 2 MG | Tablet (Extended-Release) | Marketed | Sandoz Canada Incorporated |
| Intuniv | United States | 1MG BASE, 2MG BASE, 3MG BASE … | tablet, extended release | Marketed | Takeda Pharms USA |
| Tenex | United States | 1MG BASE, 2MG BASE, 3MG BASE | tablet | Not marketed | Promius Pharma |
| Intuniv 1mg comprimidos de liberacion prolongada | Spain | 1,14 mg | comprimido de liberación prolongada | Marketed | Takeda Pharmaceuticals International Ag Ireland Branch |